Table 3.

Diabetes management and other outcomes at baseline, 3, 6 and 12 months

	TEDDY (N=37) baseline	Community (N=35) baseline	Mean Diff (95% CI)ˆ	TEDDY (N=43) 3 month	Community (N=40) 3 month	Mean Diff (95% CI)ˆ	TEDDY (N=42) 6 month	Community (N=38) 6 month	Mean Diff (95%CI)ˆ	TEDDY (N=36) 12 month	Community (N=27) 12 month	Mean Diff (95% CI)ˆ
HbA1c*, % (mmol/mol)	6.3±0.9 45+10	7.7±1.0 61+11	−1.4 −1.9, −0.8) −15 (−21, −9)	6.7±1.0 50+11	7.1±0.9 54+10	−0.4 (−0.9, 0.1) −5 (−10, 1)	7.0±1.1 53+12	7.5±1.1 58+12	−0.2 (−0.7, 0.4) −2 (−8, 4)	7.1±0.9 54+10	7.8±1.2 62+13	−0.5 (−1.1, 0.1) −6 (−12, 1)
BG† tests/day*	5.6±2.2	6.9±2.9	−0.6 (−2.3, 1.2)	6.1±2.4	6.3±2.5	−0.1 (−1.1, 0.9)	6.3±2.1	6.3±3.0	−0.1 (−1.2, 1.1)	6.6±2.2	6.2±2.6	0.6 (−0.7, 2.0)
≤2 inj/≥3 inj/pump, N(%)‡	13/15/0 (46/54/0)	0/35/0 (0/100/0)	–	13/28/1 (31/67/2)	2/35/3 (5/88/7)	–	8/30/4 (20/71/9)	1/30/7 (3/79/18)	–	6/23/6 (17/66/17)	0/17/10 (0/63/37)	–
Insulin dose* (u/kg/d)	0.3+0.2	0.4+0.2	−0.2 (−0.3, −0.1)	0.3+0.3	0.5+0.3	−0.2 (−0.3, −0.1)	0.4+0.3	0.6+0.2	−0.2 (−0.3, −0.1)	0.5+0.3	0.7+0.3	−0.2 (−0.4, −0.0)
Short acting* (u/kg/d)	0.2±0.2	0.2±0.1	−0.1 (−0.2, 0.0)	0.2±0.2	0.3±0.2	−0.1 (−0.2, −0.0)	0.2±0.2	0.3±0.2	−0.1 (−0.2, −0.0)	0.3±0.2	0.4±0.2	−0.1 (−0.3, −0.0)
Long acting*(u/kg/d)	0.1±0.1	0.2±0.1	−0.1 (−0.1, −0.0)	0.1±0.1	0.2±0.1	−0.1 (−0.1, −0.0)	0.2±0.1	0.3±0.1	−0.1 (−0.2, −0.1)	0.2±0.1	0.3±0.1	−0.1 (−0.2, 0.0)
IDAA1C*,§	7.6±1.8	9.4±1.1	−1.8 (−2.9, −0.8)	7.9±1.7	9.0±1.5	−1.1 (−1.8, −0.3)	8.5±1.7	9.7±1.5	−0.8 (−1.6, 0.0)	9.1±1.6	10.7±1.8	−1.3 (−2.4, −0.2)

Mean ± standard deviation are shown unless specified otherwise

^*missing information in some subjects

^†BG: blood glucose

^‡inj: injections

^§IDAA1C: Insulin-dose adjusted A1c: calculated as A1c (%) + [4 × insulin dose (units/kg/day)]

^ˆMean Diff (95% CI): mean difference (95% confidence intervals)